| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.757 | 0.004 | 0.757 | Antiamyloidogenic | 0.695 0.005 DBMET01426 0.617 0.007 DBMET01427 | ||
| 0.716 | 0.005 | 0.716 | Amyloid beta aggregation inhibitor | 0.691 0.005 DBMET01426 0.592 0.008 DBMET01427 | ||
| 0.319 | 0.005 | 0.319 | Beta amyloid protein antagonist | 0.304 0.005 DBMET01426 0.188 0.021 DBMET01427 | ||
| 0.27 | 0.017 | 0.27 | MAP kinase kinase 3 inhibitor | 0.215 0.085 DBMET01426 | ||
| 0.269 | 0.026 | 0.269 | Amyloid beta precursor protein antagonist | 0.208 0.052 DBMET01426 0.174 0.077 DBMET01427 | ||
| 0.311 | 0.07 | 0.341 | Nootropic | 0.341 0.057 DBMET01426 0.228 0.127 DBMET01427 | DBMET01426 | |
| 0.236 | 0.03 | 0.236 | NOS3 expression enhancer | 0.191 0.045 DBMET01426 0.207 0.038 DBMET01427 | ||
| 0.172 | 0.012 | 0.175 | Electron transport complex I inhibitor | 0.175 0.012 DBMET01426 0.167 0.014 DBMET01427 | DBMET01426 | |
| 0.165 | 0.02 | 0.165 | Gastric antisecretory | 0.099 0.068 DBMET01426 0.091 0.077 DBMET01427 | ||
| 0.157 | 0.014 | 0.21 | Phosphodiesterase 3A inhibitor | 0.21 0.007 DBMET01426 0.168 0.013 DBMET01427 | DBMET01426 | |
| 0.164 | 0.022 | 0.171 | Acetylcholine agonist | 0.171 0.02 DBMET01426 0.129 0.033 DBMET01427 | DBMET01426 | |
| 0.258 | 0.117 | 0.258 | Angiogenesis inhibitor | 0.207 0.162 DBMET01426 0.246 0.126 DBMET01427 | ||
| 0.163 | 0.022 | 0.192 | DNA repair enzyme inhibitor | 0.192 0.01 DBMET01426 0.159 0.024 DBMET01427 | DBMET01426 | |
| 0.176 | 0.043 | 0.178 | Phosphodiesterase inhibitor | 0.178 0.042 DBMET01426 0.122 0.08 DBMET01427 | DBMET01426 | |
| 0.136 | 0.007 | 0.142 | Acetylcholine M5 receptor agonist | 0.142 0.005 DBMET01426 0.129 0.008 DBMET01427 | DBMET01426 | |
| 0.124 | 0.008 | 0.124 | Potassium channel (ATP-sensitive) blocker | 0.098 0.016 DBMET01426 0.09 0.02 DBMET01427 | ||
| 0.179 | 0.064 | 0.179 | MAP kinase kinase 5 inhibitor | 0.158 0.121 DBMET01426 | ||
| 0.179 | 0.065 | 0.185 | Antipruritic | 0.185 0.06 DBMET01426 0.167 0.076 DBMET01427 | DBMET01426 | |
| 0.131 | 0.018 | 0.131 | Raf kinase C inhibitor | 0.079 0.033 DBMET01426 0.073 0.035 DBMET01427 | ||
| 0.267 | 0.169 | 0.267 | MAP kinase kinase 6 inhibitor | |||
| 0.108 | 0.012 | 0.123 | Caspase 9 inhibitor | 0.123 0.009 DBMET01426 0.112 0.011 DBMET01427 | DBMET01426 | |
| 0.248 | 0.157 | 0.248 | Histamine release inhibitor | 0.23 0.172 DBMET01427 | ||
| 0.093 | 0.013 | 0.121 | Phosphodiesterase 3B inhibitor | 0.121 0.008 DBMET01426 0.096 0.012 DBMET01427 | DBMET01426 | |
| 0.129 | 0.048 | 0.161 | Caspase 3 inhibitor | 0.112 0.072 DBMET01426 0.161 0.021 DBMET01427 | DBMET01427 | |
| 0.113 | 0.036 | 0.113 | Phosphodiesterase IV inhibitor | 0.096 0.048 DBMET01426 | ||
| 0.087 | 0.01 | 0.091 | Acetylcholine M2 receptor agonist | 0.091 0.009 DBMET01426 0.08 0.013 DBMET01427 | DBMET01426 | |
| 0.136 | 0.061 | 0.136 | Antibacterial (Helicobacter pylori) | 0.122 0.078 DBMET01427 | ||
| 0.135 | 0.062 | 0.234 | Cyclooxygenase 3 inhibitor | 0.174 0.031 DBMET01426 0.234 0.01 DBMET01427 | DBMET01427 | |
| 0.108 | 0.038 | 0.108 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.088 | 0.03 | 0.088 | Phosphodiesterase VI inhibitor | 0.069 0.064 DBMET01426 | ||
| 0.097 | 0.042 | 0.117 | MAP-kinase-activated kinase inhibitor | 0.117 0.027 DBMET01426 0.079 0.064 DBMET01427 | DBMET01426 | |
| 0.09 | 0.035 | 0.113 | MAP-kinase-activated kinase 2 inhibitor | 0.113 0.023 DBMET01426 0.073 0.054 DBMET01427 | DBMET01426 | |
| 0.071 | 0.017 | 0.071 | H+/K+-transporting ATPase inhibitor | 0.06 0.025 DBMET01426 | ||
| 0.051 | 0.004 | 0.058 | Caspase 6 inhibitor | 0.053 0.004 DBMET01426 0.058 0.004 DBMET01427 | DBMET01427 | |
| 0.082 | 0.038 | 0.094 | Phosphodiesterase 5A inhibitor | 0.094 0.03 DBMET01426 0.07 0.05 DBMET01427 | DBMET01426 | |
| 0.079 | 0.037 | 0.102 | Secretase beta inhibitor | 0.102 0.017 DBMET01426 0.098 0.019 DBMET01427 | DBMET01426 | |
| 0.064 | 0.025 | 0.064 | mTOR inhibitor | 0.051 0.037 DBMET01426 0.051 0.037 DBMET01427 | ||
| 0.147 | 0.109 | 0.168 | Platelet adhesion inhibitor | 0.168 0.09 DBMET01426 0.152 0.103 DBMET01427 | DBMET01426 | |
| 0.131 | 0.094 | 0.2 | Hemostatic | 0.2 0.033 DBMET01426 0.192 0.036 DBMET01427 | DBMET01426 | |
| 0.064 | 0.028 | 0.064 | Phosphodiesterase 4A inhibitor | 0.06 0.03 DBMET01426 | ||
| 0.078 | 0.043 | 0.088 | Phosphodiesterase V inhibitor | 0.088 0.034 DBMET01426 0.066 0.056 DBMET01427 | DBMET01426 | |
| 0.037 | 0.01 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.02 DBMET01426 | ||
| 0.084 | 0.057 | 0.094 | Histamine H2 receptor antagonist | 0.094 0.041 DBMET01426 | DBMET01426 | |
| 0.071 | 0.044 | 0.076 | Neuronal nicotinic receptor antagonist | 0.076 0.04 DBMET01426 | DBMET01426 | |
| 0.039 | 0.015 | 0.077 | Acetylcholine M4 receptor agonist | 0.077 0.006 DBMET01426 0.034 0.018 DBMET01427 | DBMET01426 | |
| 0.065 | 0.042 | 0.065 | DNA gyrase inhibitor | |||
| 0.049 | 0.028 | 0.061 | Phosphodiesterase X inhibitor | 0.061 0.02 DBMET01426 | DBMET01426 | |
| 0.049 | 0.028 | 0.061 | Phosphodiesterase 10A inhibitor | 0.061 0.02 DBMET01426 | DBMET01426 | |
| 0.108 | 0.087 | 0.108 | Epidermal growth factor receptor kinase inhibitor | 0.101 0.097 DBMET01426 | ||
| 0.098 | 0.081 | 0.103 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.079 DBMET01426 0.103 0.073 DBMET01427 | DBMET01427 | |
| 0.198 | 0.182 | 0.283 | Apoptosis antagonist | 0.283 0.097 DBMET01426 0.265 0.114 DBMET01427 | DBMET01426 | |
| 0.063 | 0.049 | 0.085 | Phosphodiesterase III inhibitor | 0.085 0.032 DBMET01426 0.064 0.048 DBMET01427 | DBMET01426 | |
| 0.27 | 0.256 | 0.27 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.072 | 0.06 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 DBMET01426 | DBMET01426 | |
| 0.075 | 0.064 | 0.075 | Acetylcholine nicotinic agonist | |||
| 0.036 | 0.025 | 0.037 | ATM kinase inhibitor | 0.037 0.023 DBMET01426 0.035 0.029 DBMET01427 | DBMET01426 | |
| 0.116 | 0.106 | 0.146 | Sphingosine 1-phosphate receptor 2 antagonist | 0.146 0.047 DBMET01427 | DBMET01427 | |
| 0.073 | 0.063 | 0.075 | Acetylcholine nicotinic antagonist | 0.075 0.061 DBMET01426 | DBMET01426 | |
| 0.022 | 0.012 | 0.027 | Hexokinase stimulant | 0.02 0.014 DBMET01426 0.027 0.009 DBMET01427 | DBMET01427 | |
| 0.013 | 0.006 | 0.013 | Calcineurin inhibitor | 0.013 0.006 DBMET01426 0.012 0.007 DBMET01427 | ||
| 0.054 | 0.047 | 0.06 | Protein kinase C theta inhibitor | 0.06 0.037 DBMET01426 | DBMET01426 | |
| 0.069 | 0.067 | 0.069 | Fibroblast growth factor 3 antagonist | |||
| 0.022 | 0.021 | 0.022 | Phosphodiesterase 6A inhibitor | |||
| 0.086 | 0.086 | 0.103 | Nitric-oxide synthase inhibitor | 0.103 0.055 DBMET01426 | DBMET01426 | |
| 0.047 | 0.048 | 0.057 | Acetylcholine muscarinic agonist | 0.057 0.036 DBMET01426 | DBMET01426 | |
| 0.136 | 0.137 | 0.146 | Antimitotic | 0.146 0.125 DBMET01426 | DBMET01426 | |
| 0.075 | 0.079 | 0.091 | Thioredoxin reductase inhibitor | 0.091 0.039 DBMET01426 0.084 0.052 DBMET01427 | DBMET01426 | |
| 0.083 | 0.091 | 0.1 | Interleukin 12 antagonist | 0.096 0.061 DBMET01426 0.1 0.053 DBMET01427 | DBMET01427 | |
| 0.065 | 0.076 | 0.075 | Keratolytic | 0.075 0.056 DBMET01426 0.07 0.064 DBMET01427 | DBMET01426 | |
| 0.013 | 0.025 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 DBMET01426 | DBMET01426 | |
| 0.042 | 0.055 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.041 DBMET01426 | DBMET01426 | |
| 0.153 | 0.174 | 0.223 | ErbB-1 antagonist | 0.223 0.068 DBMET01426 0.169 0.134 DBMET01427 | DBMET01426 | |
| 0.07 | 0.094 | 0.087 | Protein kinase C delta inhibitor | 0.087 0.066 DBMET01426 | DBMET01426 | |
| 0.034 | 0.06 | 0.044 | Guanylate cyclase stimulant | 0.044 0.028 DBMET01426 | DBMET01426 | |
| 0.075 | 0.103 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 DBMET01426 | DBMET01426 | |
| 0.098 | 0.128 | 0.132 | Cyclooxygenase inhibitor | 0.132 0.086 DBMET01426 | DBMET01426 | |
| 0.029 | 0.062 | 0.039 | Acetyl-CoA carboxylase inhibitor | 0.039 0.032 DBMET01427 | DBMET01427 | |
| 0.064 | 0.098 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.085 0.054 DBMET01426 | DBMET01426 | |
| 0.084 | 0.12 | 0.108 | Nav1.5 sodium channel blocker | 0.108 0.072 DBMET01426 | DBMET01426 | |
| 0.037 | 0.079 | 0.08 | Adenosine A2a receptor antagonist | 0.08 0.032 DBMET01426 | DBMET01426 | |
| 0.082 | 0.125 | 0.153 | Cyclooxygenase 1 inhibitor | 0.153 0.055 DBMET01426 | DBMET01426 | |
| 0.071 | 0.117 | 0.093 | Polo-like kinase-4 inhibitor | 0.093 0.085 DBMET01426 | DBMET01426 | |
| 0.092 | 0.142 | 0.123 | Activin receptor-like kinase 2 inhibitor | 0.123 0.093 DBMET01426 | DBMET01426 | |
| 0.09 | 0.15 | 0.125 | Interleukin 1 antagonist | 0.125 0.081 DBMET01426 | DBMET01426 | |
| 0.044 | 0.104 | 0.076 | Amidase inhibitor | 0.076 0.042 DBMET01427 | DBMET01427 | |
| 0.061 | 0.125 | 0.089 | Breast cancer-resistant protein inhibitor | 0.089 0.068 DBMET01426 | DBMET01426 | |
| 0.07 | 0.134 | 0.144 | Toll-Like receptor 3 antagonist | 0.144 0.016 DBMET01426 | DBMET01426 | |
| 0.184 | 0.25 | 0.224 | Antibacterial | 0.224 0.203 DBMET01426 | DBMET01426 | |
| 0.097 | 0.164 | 0.143 | Heat shock protein 90 antagonist | 0.143 0.082 DBMET01426 | DBMET01426 | |
| 0.034 | 0.101 | 0.065 | Adenosine A2 receptor antagonist | 0.065 0.043 DBMET01426 | DBMET01426 | |
| 0.103 | 0.172 | 0.18 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.18 0.093 DBMET01426 0.153 0.117 DBMET01427 | DBMET01426 | |
| 0.112 | 0.186 | 0.202 | Non-steroidal antiinflammatory agent | 0.202 0.069 DBMET01426 0.156 0.108 DBMET01427 | DBMET01426 | |
| 0.133 | 0.211 | 0.176 | Hypoglycemic | 0.176 0.14 DBMET01426 | DBMET01426 | |
| 0.034 | 0.117 | 0.059 | Sodium/calcium exchanger inhibitor | 0.059 0.02 DBMET01426 | DBMET01426 | |
| 0.208 | 0.293 | 0.263 | 5 Hydroxytryptamine release inhibitor | 0.263 0.21 DBMET01427 | DBMET01427 | |
| 0.092 | 0.178 | 0.131 | TRKC antagonist | 0.131 0.119 DBMET01426 | DBMET01426 | |
| 0.133 | 0.244 | 0.189 | DNA synthesis inhibitor | 0.189 0.14 DBMET01426 | DBMET01426 | |
| 0.06 | 0.184 | 0.112 | Interleukin 1b antagonist | 0.112 0.069 DBMET01426 0.103 0.077 DBMET01427 | DBMET01426 | |
| 0.026 | 0.166 | 0.065 | Catalase inhibitor | 0.065 0.06 DBMET01427 | DBMET01427 | |
| 0.086 | 0.244 | 0.136 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.103 DBMET01426 0.136 0.05 DBMET01427 | DBMET01427 | |
| 0.126 | 0.286 | 0.193 | Neuropeptide Y2 antagonist | 0.193 0.132 DBMET01427 | DBMET01427 | |
| 0.036 | 0.198 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.06 DBMET01426 | DBMET01426 | |
| 0.065 | 0.291 | 0.149 | Interleukin antagonist | 0.149 0.119 DBMET01427 | DBMET01427 | |
| 0.016 | 0.298 | 0.084 | Neuraminidase (influenza) inhibitor | 0.084 0.023 DBMET01427 | DBMET01427 | |
| 0.009 | 0.358 | 0.081 | Neuraminidase inhibitor | 0.081 0.025 DBMET01427 | DBMET01427 | |
| 0.049 | 0.634 | 0.145 | Lipocortins synthesis antagonist | 0.145 0.113 DBMET01426 | DBMET01426 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |